119
Participants
Start Date
March 9, 2022
Primary Completion Date
August 12, 2022
Study Completion Date
September 8, 2022
Obicetrapib
tablets
Ezetimibe 10mg
capsules; 10 mg ezetimibe tablets filled into capsule shells, 1 tablet per capsule.
Obicetrapib placebo
tablets; no active ingredient
Ezetimibe placebo
capsules; no active ingredient
Meridian Clinical Research - Savannah, GA, Savannah
Progressive Medical Research, Port Orange
A & R Research Group, LLC, Pembroke Pines
Ocala Cardiovascular Research, Ocala
Research Integrity LLC, Owensboro
Aventiv Research, Inc., Columbus
Summit Research Group, LLC, Munroe Falls
Meridian Clinical Research- Springdale, OH, Cincinnati
Midwest Institute for Clinical Research, Indianapolis
Oakland Medical Research Center, Troy
Mercury Street Medical, Butte
Northwest Heart Clinical Research, LLC, Arlington Heights
Biofortis, Inc, Addison
Velocity Clinical Research, Meridian
Velocity Clinical Research - Westlake d.b.a National Research Institute, Los Angeles
Valley Clinical Trials, Inc., Northridge
Lead Sponsor
NewAmsterdam Pharma
INDUSTRY